20 June 2022

How to make the most of AI in biopharma research–Nature Feature

Rapidly accelerating data generation has outgrown the rate at which human beings can digest in a meaningful way… artificial intelligence will become a necessity, not just a novelty, for biotech.

Erwin Seinin, eLabNext founder and managing director

In this ad feature with Springer Nature Group [Nature Magazine], we share how to make the most of artificial intelligence (AI) in biopharma research–especially in creating an optimized and interconnected workflow when working with an ELN platform.

This article features:

  • Taylor Chartier from Modicus Prime
  • Vadim Nazarov from ImmunoMind.
  • Plus: Erwin Seinen and Zareh Zurabyan from eLabNext

Read the article here

< Back to overview

Featured News

scientists in lab

The digital lab: in search of leaner, greener operations–Nature Feature

Laboratories consume between give and ten times more energy than commercial office spaces per square foot, and about four times more water. Rachael Relph, chief

Learn more

Lab Automation, AI & Digital Transformation–New SelectScience article feature

Laboratory research in the past decade has moved vastly into paperless processes. New technologies and tools are entering the market every day to aid and

Learn more

Integrating AI with digital lab tools–SelectScience Article

Artificial intelligence (AI) tools may be the next step needed to revolutionize life science research; however, many R&D companies are not internally equipped to build

Learn more

Get started with eLabNext today

Personal demo, free lab workflow assessment, and friendly expert guidance.